# Letrozole in Patients With Hepatopulmonary Syndrome

> **NCT04577001** · PHASE2 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 1 (actual)

## Conditions studied

- Hepatopulmonary Syndrome

## Interventions

- **DRUG:** Letrozole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04577001
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-18
- **Primary completion:** 2021-03-26
- **Final completion:** 2021-03-26
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low Recruitment Numbers
- **Last updated:** 2024-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04577001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04577001, "Letrozole in Patients With Hepatopulmonary Syndrome". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04577001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*